Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18205878rdf:typepubmed:Citationlld:pubmed
pubmed-article:18205878lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:18205878lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:18205878lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:18205878lifeskim:mentionsumls-concept:C0221912lld:lifeskim
pubmed-article:18205878lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:18205878lifeskim:mentionsumls-concept:C2266856lld:lifeskim
pubmed-article:18205878lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:18205878pubmed:issue3lld:pubmed
pubmed-article:18205878pubmed:dateCreated2008-2-15lld:pubmed
pubmed-article:18205878pubmed:abstractTextCutaneous malignant melanoma is an aggressive type of skin cancer which causes disproportionate mortality in young and middle-aged adults. Once disseminated, melanoma can be considered an incurable disease, highly resistant to standard antineoplastic treatment, such as chemotherapy or radiation therapy. The proteasome represents a novel target for cancer therapy that can potentially be used in melanoma.lld:pubmed
pubmed-article:18205878pubmed:languageenglld:pubmed
pubmed-article:18205878pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18205878pubmed:citationSubsetIMlld:pubmed
pubmed-article:18205878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18205878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18205878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18205878pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18205878pubmed:statusMEDLINElld:pubmed
pubmed-article:18205878pubmed:monthMarlld:pubmed
pubmed-article:18205878pubmed:issn0007-0963lld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:SmithG NGNlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:LlombartAAlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:CasanovaJ MJMlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:Matias-GuiuXXlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:VilellaRRlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:EgidoRRlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:MartiR MRMlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:Schoenenberge...lld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:LlobetDDlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:DolcetXXlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:SorollaAAlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:YeramianAAlld:pubmed
pubmed-article:18205878pubmed:authorpubmed-author:Pérez de...lld:pubmed
pubmed-article:18205878pubmed:issnTypePrintlld:pubmed
pubmed-article:18205878pubmed:volume158lld:pubmed
pubmed-article:18205878pubmed:ownerNLMlld:pubmed
pubmed-article:18205878pubmed:authorsCompleteYlld:pubmed
pubmed-article:18205878pubmed:pagination496-504lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:meshHeadingpubmed-meshheading:18205878...lld:pubmed
pubmed-article:18205878pubmed:year2008lld:pubmed
pubmed-article:18205878pubmed:articleTitleEffect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines.lld:pubmed
pubmed-article:18205878pubmed:affiliationDepartment of Dermatology, and Laboratory of Research, Hospital Universitair Arnau de Vilanova, Universitat de Lleida, 25198 Lleida, Spain.lld:pubmed
pubmed-article:18205878pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18205878pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18205878lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18205878lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18205878lld:pubmed